Jinghua Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 6/6
Jinghua Pharmaceutical Group has a total shareholder equity of CN¥2.9B and total debt of CN¥14.9M, which brings its debt-to-equity ratio to 0.5%. Its total assets and total liabilities are CN¥3.2B and CN¥324.6M respectively. Jinghua Pharmaceutical Group's EBIT is CN¥251.7M making its interest coverage ratio -6.6. It has cash and short-term investments of CN¥1.3B.
Key information
0.5%
Debt to equity ratio
CN¥14.91m
Debt
| Interest coverage ratio | -6.6x |
| Cash | CN¥1.34b |
| Equity | CN¥2.90b |
| Total liabilities | CN¥324.60m |
| Total assets | CN¥3.23b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002349's short term assets (CN¥2.1B) exceed its short term liabilities (CN¥306.2M).
Long Term Liabilities: 002349's short term assets (CN¥2.1B) exceed its long term liabilities (CN¥18.4M).
Debt to Equity History and Analysis
Debt Level: 002349 has more cash than its total debt.
Reducing Debt: 002349's debt to equity ratio has reduced from 21.2% to 0.5% over the past 5 years.
Debt Coverage: 002349's debt is well covered by operating cash flow (1866.4%).
Interest Coverage: 002349 earns more interest than it pays, so coverage of interest payments is not a concern.